Molecular diagnosis of mature lymphoproliferative disorders

被引：0

作者：

Boulland, M. -L. ^{[1
]}

Fest, T. ^{[1
]}

机构：

[1] CHU Pontchaillou, Serv Hematol Biol, Mol Biol Lab, F-35033 Rennes 9, France

来源：

ONCOLOGIE | 2011年 / 13卷 / 09期

关键词：

Lymphomas; Lymphoproliferation; Molecular diagnosis; B lymphocytes; MANTLE CELL LYMPHOMA; CHRONIC LYMPHOCYTIC-LEUKEMIA; EXPRESSION; GENE; PCR;

D O I：

10.1007/s10269-011-2061-5

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The understanding of the molecular mechanisms associated to lymphoid neoplasia has significantly improved in recent years due to technological advances. Molecular markers have been identified, allowing initial diagnosis. Genomic rearrangements can help to affirm clonality or indicate the disease entity. Some markers are also researched for their prognostic value. Finally, some rearrangements can be used for residual disease assessment during clinical course. To cite this journal: Oncologie 13 (2011).

引用

页码：537 / 541

页数：5

共 14 条

[1] Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling [J].

Alizadeh, AA ;

Eisen, MB ;

Davis, RE ;

Ma, C ;

Lossos, IS ;

Rosenwald, A ;

Boldrick, JG ;

Sabet, H ;

Tran, T ;

Yu, X ;

Powell, JI ;

Yang, LM ;

Marti, GE ;

Moore, T ;

Hudson, J ;

Lu, LS ;

Lewis, DB ;

Tibshirani, R ;

Sherlock, G ;

Chan, WC ;

Greiner, TC ;

Weisenburger, DD ;

Armitage, JO ;

Warnke, R ;

Levy, R ;

Wilson, W ;

Grever, MR ;

Byrd, JC ;

Botstein, D ;

Brown, PO ;

Staudt, LM .

NATURE, 2000, 403 (6769) :503-511

[2] Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies Report of the BIOMED-2 Concerted Action BHM4 CT98-3936 [J].

Brueggemann, M. ;

White, H. ;

Gaulard, P. ;

Garcia-Sanz, R. ;

Gameiro, P. ;

Oeschger, S. ;

Jasani, B. ;

Ott, M. ;

Delsol, G. ;

Orfao, A. ;

Tiemann, M. ;

Herbst, H. ;

Langerak, A. W. ;

Spaargaren, M. ;

Moreau, E. ;

Groenen, P. J. T. A. ;

Sambade, C. ;

Foroni, L. ;

Carter, G. I. ;

Hummel, M. ;

Bastard, C. ;

Davi, F. ;

Delfau-Larue, M. -H. ;

Kneba, M. ;

van Dongen, J. J. M. ;

Beldjord, K. ;

Molina, T. J. .

LEUKEMIA, 2007, 21 (02) :215-221

[3] The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications [J].

Campo, Elias ;

Swerdlow, Steven H. ;

Harris, Nancy L. ;

Pileri, Stefano ;

Stein, Harald ;

Jaffe, Elaine S. .

BLOOD, 2011, 117 (19) :5019-5032

[4] Cyclin D1-negative mantle cell lymphoma:: a clinicopathologic study based on gene expression profiling [J].

Fu, K ;

Weisenburger, DD ;

Greiner, TC ;

Dave, S ;

Wright, G ;

Rosenwald, A ;

Chiorazzi, M ;

Iqbal, J ;

Gesk, S ;

Siebert, R ;

De Jong, D ;

Jaffe, ES ;

Wilson, WH ;

Delabie, J ;

Ott, G ;

Dave, BJ ;

Sanger, WG ;

Smith, LM ;

Rimsza, L ;

Braziel, RM ;

Müller-Hermelink, HK ;

Campo, E ;

Gascoyne, RD ;

Staudt, LM ;

Chan, WC .

BLOOD, 2005, 106 (13) :4315-4321

[5] ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia [J].

Ghia, P. ;

Stamatopoulos, K. ;

Belessi, C. ;

Moreno, C. ;

Stilgenbauer, S. ;

Stevenson, F. ;

Davi, F. ;

Rosenquist, R. .

LEUKEMIA, 2007, 21 (01) :1-3

[6] Unmutated Ig VH genes are associated with a more aggressive form of chronic lymphocytic leukemia [J].

Hamblin, TJ ;

Davis, Z ;

Gardiner, A ;

Oscier, DG ;

Stevenson, FK .

BLOOD, 1999, 94 (06) :1848-1854

[7] Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray [J].

Hans, CP ;

Weisenburger, DD ;

Greiner, TC ;

Gascoyne, RD ;

Delabie, J ;

Ott, G ;

Müller-Hermelink, HK ;

Campo, E ;

Braziel, RM ;

Jaffe, ES ;

Pan, ZG ;

Farinha, P ;

Smith, LM ;

Falini, B ;

Banham, AH ;

Rosenwald, A ;

Staudt, LM ;

Connors, JM ;

Armitage, JO ;

Chan, WC .

BLOOD, 2004, 103 (01) :275-282

[8] Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes [J].

Lossos, IS ;

Czerwinski, DK ;

Alizadeh, AA ;

Wechser, MA ;

Tibshirani, R ;

Botstein, D ;

Levy, R .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (18) :1828-1837

[9] SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype [J].

Mozos, Ana ;

Royo, Cristina ;

Hartmann, Elena ;

De Jong, Daphne ;

Baro, Cristina ;

Valera, Alexandra ;

Fu, Kai ;

Weisenburger, Dennis D. ;

Delabie, Jan ;

Chuang, Shih-Sung ;

Jaffe, Elaine S. ;

Ruiz-Marcellan, Carmen ;

Dave, Sandeep ;

Rimsza, Lisa ;

Braziel, Rita ;

Gascoyne, Randy D. ;

Sole, Francisco ;

Lopez-Guillermo, Armando ;

Colomer, Dolors ;

Staudt, Louis M. ;

Rosenwald, Andreas ;

Ott, German ;

Jares, Pedro ;

Campo, Elias .

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (11) :1555-1562

[10] Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study [J].

Pott, Christiane ;

Hoster, Eva ;

Delfau-Larue, Marie-Helene ;

Beldjord, Kheira ;

Boettcher, Sebastian ;

Asnafi, Vahid ;

Plonquet, Anne ;

Siebert, Reiner ;

Callet-Bauchu, Evelyne ;

Andersen, Niels ;

van Dongen, Jacques J. M. ;

Klapper, Wolfram ;

Berger, Francoise ;

Ribrag, Vincent ;

van Hoof, Achiel L. ;

Trneny, Marek ;

Walewski, Jan ;

Dreger, Peter ;

Unterhalt, Michael ;

Hiddemann, Wolfgang ;

Kneba, Michael ;

Kluin-Nelemans, Hanneke C. ;

Hermine, Olivier ;

Macintyre, Elizabeth ;

Dreyling, Martin .

BLOOD, 2010, 115 (16) :3215-3223

← 1 2 →